Kavanaugh William Michael 4
4 · CytomX Therapeutics, Inc. · Filed Oct 6, 2017
Insider Transaction Report
Form 4
Kavanaugh William Michael
CSO, Head Res.&Non-Clin. Dev.
Transactions
- Exercise/Conversion
Common Stok
2017-10-04$4.47/sh+48,368$216,340→ 62,285 total - Sale
Common Stock
2017-10-04$24.34/sh−48,368$1,177,277→ 13,917 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-10-04−48,368→ 48,368 totalExercise: $4.47Exp: 2025-05-06→ Common Stock (48,368 underlying)
Footnotes (2)
- [F1]The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- [F2]The shares subject to the option are fully vested and exercisable.